USPTO serial 85869230
Serial No. 85869230
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEAN, AMY C
- Law office
- TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with Serial No. 85869230?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Acne medications; Allergy medications; Allergy relief medication; Antiallergic medicines; Bacteriostats for medicinal, dental and veterinary use; Biological fungicides; Biological indicators for monitoring sterilization processes for medical or veterinary purposes; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological tissue grafts; Biological bone, skin tissue intended for subsequent implantation; Bone growth media consisting of biological materials for medical purposes; Bone void fillers consisting of biological materials; Burn relief medication; Candy for medical purposes; Chemical preparations for sanitary purposes; Chemical reagents for medical or veterinary purposes; Diarrhea medication; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for treating constipation; Dietary fiber to aid digestion; Dietetic foods, namely, pasta, crackers adapted for medical use; Dietetic sugar for medical use; Dietetic sugar substitutes for medical use; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Fungal medications; Ground flaxseed fiber for use as a dietary supplement; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Liquid nutritional supplement; Liquid protein supplements; Liquid vitamin supplements; Medical diagnostic reagents and assays for testing of body fluids; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Nutritive substances for microorganisms for medical purposes; Pain relief medication; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Stimulatory medications for use in weight reduction programs; Sulphonamides as medicines; Transdermal patches featuring smoking cessation preparations, caffeine for use as a stimulant, vitamins for increasing energy; Vegan liquid protein supplements; Veterinary preparations, namely, pain relief medication; Vitamin tablets | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 17, 2014 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 16, 2014 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 20, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2013 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 12, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2013 | NWAP | NEW APPLICATION ENTERED | — |